DESIREE WASHBURN: Open Payments
NPI 1104078468 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,711 in 107 payments from 22 companies in 2025. Trend: 2023 $1,968 · 2024 $1,817 · 2025 $3,711
Food & beverage: $2,667Travel & lodging: $1,044
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 14 | $1,374 |
| GENZYME CORPORATION | 7 | $294 |
| AstraZeneca Pharmaceuticals LP | 14 | $267 |
| JAZZ PHARMACEUTICALS INC. | 6 | $259 |
| Insmed, Inc. | 10 | $254 |
| Axsome Therapeutics, Inc. | 11 | $176 |
| GlaxoSmithKline, LLC. | 8 | $171 |
| Regeneron Healthcare Solutions, Inc. | 4 | $126 |
| Grifols USA, LLC | 4 | $120 |
| Philips North America LLC | 5 | $101 |
Products named: INSPIRE, DUPIXENT, XYWAV, Arikayce, AIRSUPRA, Sunosi, TRELEGY ELLIPTA, Prolastin-C Liquid.
Industry payments across AL — which companies pay providers there.
